PharmX Technologies (ASX:PHX) renewed its long-standing National Diabetes Services Scheme agreement, and a 12-month extension to the existing arrangement began July 1, according to a Friday Australian bourse filing.
It also secured partnerships with over 50 new suppliers across Australia and New Zealand during the fiscal year ended June 30, bringing the total number of active suppliers on its platform to over 170.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.